Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2401 USD | -7.65% | -1.03% | -86.81% |
Apr. 15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Apr. 12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.81% | 5.14M | |
+1.28% | 42.86B | |
+11.58% | 42.74B | |
+45.26% | 41.36B | |
-8.83% | 27.68B | |
+7.57% | 25.15B | |
-22.95% | 18.63B | |
+29.69% | 12.37B | |
-2.44% | 11.92B | |
+7.57% | 11.21B |
- Stock Market
- Equities
- PRTG Stock
- News Portage Biotech Inc.
- Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating